Tissue Swelling, also known as edema, is a condition characterized by the abnormal accumulation of fluid within the interstitial spaces of tissues. This can result from various factors, including inflammation, injury, infection, or underlying medical conditions. Increased permeability of blood vessels allows fluid, proteins, and other substances to leak into the surrounding tissues, leading to swelling. Commonly affected areas include the extremities, face, and abdomen. The severity of tissue swelling can range from mild discomfort to significant impairment of organ function. Clinical evaluation often involves assessing the affected area for signs of redness, warmth, and tenderness. Imaging techniques such as ultrasound or MRI may be utilized to visualize the extent of swelling. Treatment approaches may include addressing the underlying cause, such as managing inflammation, infection, or improving circulation. Elevation of the affected body part, compression garments, and lifestyle modifications are often recommended. In certain cases, severe or persistent swelling may require medical intervention to prevent complications. Understanding the underlying mechanisms and contributing factors to tissue swelling is crucial for developing targeted treatment strategies and improving the overall management of edematous conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy